Cited by 281Alzheimer's disease research and treatmentsBarrier Structure and Function StudiesNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.

Lipopolysaccharide alters the blood–brain barrier transport of amyloid β protein: A mechanism for inflammation in the progression of Alzheimer’s disease

Open access

Jaeger, Laura B., Dohgu, Shinya, Sultana, Rukhsana, Lynch, Jessica L., Owen, Joshua B., Erickson, Michelle A., Shah, Gul N., Price, Tulin O., Fleegal-Demotta, Melissa A., Butterfiled, D. Allan, Banks, William A.·2009·Brain, Behavior, and Immunity

DOI 10.1016/j.bbi.2009.01.017PMC PMC2783557

Open this paper in CoChat — free account

Abstract

Alzheimer's disease (AD) brains are characterized by accumulation of amyloid beta protein (Abeta) and neuroinflammation. Increased blood-to-brain influx and decreased brain-to-blood efflux across the blood-brain barrier (BBB) have been proposed as mechanisms for Abeta accumulation. Epidemiological studies suggest that the nonsteroidal anti-inflammatory drug (NSAID) indomethacin slows the progression of AD. We hypothesized that inflammation alters BBB handling of Abeta. Mice treated with lipopolysaccharide (LPS) had increased brain influx and decreased brain efflux of Abeta, recapitulating the findings in AD. Neither influx nor efflux was mediated by LPS acting directly on BBB cells. Increased influx was mediated by a blood-borne factor, indomethacin-independent, blocked by the triglyceride triolein, and not related to expression of the blood-to-brain transporter of Abeta, RAGE. Serum levels of IL-6, IL-10, IL-13, and MCP-1 mirrored changes in Abeta influx. Decreased efflux was blocked by indomethacin and accompanied by decreased protein expression of the brain-to-blood transporter of Abeta, LRP-1. LPS paradoxically increased expression of neuronal LRP-1, a major source of Abeta. Thus, inflammation potentially increases brain levels of Abeta by three mechanisms: increased influx, decreased efflux, and increased neuronal production.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.bbi.2009.01.017

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Methods in Enzymology , Vol
Colowick, S. P., Joshi, M. D., Jagannathan, & KAPLAN, N. O. (1966) · Cited by 26,137
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,565
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J., Knapp, D. J., & Crews, F. T. (2007) · Glia · doi:10.1002/glia.20467 · Cited by 2,144
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,426
Clearance of Alzheimer’s amyloid-β1-40 peptide from brain by LDL receptor–related protein-1 at the blood-brain barrier
Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413
Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide
Butterfield, D. A., Drake, J., Pocernich, C., & Castegna, A. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02173-6 · Cited by 1,114
LRP/Amyloid β-Peptide Interaction Mediates Differential Brain Efflux of Aβ Isoforms
Deane, R., Wu, Z., Sagare, A., Davis, J., Du Yan, S., Hamm, K., Xu, F., Parisi, M., LaRue, B., Hu, H. W., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.017 · Cited by 828
Transport Pathways for Clearance of Human Alzheimer's Amyloid β-Peptide and Apolipoproteins E and J in the Mouse Central Nervous System
Bell, R. D., Sagare, A. P., Friedman, A. E., Bedi, G. S., Holtzman, D. M., Deane, R., & Zlokovic, B. V. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600419 · Cited by 670

Show all 64 references

Sorted by citations

Items 101–200 of 281

Tempol and perindopril protect against lipopolysaccharide-induced cognition impairment and amyloidogenesis by modulating brain-derived neurotropic factor, neuroinflammation and oxido-nitrosative stress
Ali, M. R. A., Abo‐Youssef, A. M., Messiha, B. A. S., & Khattab, M. M. (2016) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-016-1234-6 · Cited by 61
Mechanisms of Dendritic Cell Trafficking Across the Blood–brain Barrier
Sagar, D., Foss, C., El Baz, R., Pomper, M. G., Khan, Z. K., & Jain, P. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9302-7 · Cited by 60
From Dysbiosis to Neurodegenerative Diseases through Different Communication Pathways: An Overview
Intili, G., Paladino, L., Rappa, F., Alberti, G., Plicato, A., Calabrò, F., Fucarino, A., Cappello, F., Bucchieri, F., Tomasello, G., et al. (2023) · Biology · doi:10.3390/biology12020195 · Cited by 66
Chronic Sleep Restriction Induces Aβ Accumulation by Disrupting the Balance of Aβ Production and Clearance in Rats
Zhao, B., Liu, P., Wei, M., Li, Y., Liu, J., Ma, L., Shang, S., Jiang, Y., Huo, K., Wang, J., et al. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02719-2 · Cited by 63
Inflammatory Risk Factors and Pathologies Associated with Alzheimers Disease
Sastre, M., Richardson, J. C., Gentleman, S., & Brooks, D. J. (2011) · Current Alzheimer Research · doi:10.2174/156720511795256062 · Cited by 59
Vitamin D3 attenuates lipopolysaccharide-induced cognitive impairment in rats by inhibiting inflammation and oxidative stress
Mokhtari‐Zaer, A., Hosseini, M., Salmani, H., Arab, Z., & Zareian, P. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117703 · Cited by 59
Folate nutrition and blood–brain barrier dysfunction
Stover, P. J., Durga, J., & Field, M. S. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.01.006 · Cited by 59
Microbiota-gut-brain axis and Alzheimer’s disease: Implications of the blood-brain barrier as an intervention target
Liu, S., Gao, J., Liu, K., & Zhang, H. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111560 · Cited by 59
Inhibition of 2-AG hydrolysis differentially regulates blood brain barrier permeability after injury
Piro, J. R., Suidan, G. L., Quan, J., Pi, Y., O'Neill, S., Ilardi, M. C., Pozdnyakov, N., Lanz, T. A., Xi, H. S., Bell, R. D., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1166-9 · Cited by 56
Diet, Microbiota and Brain Health: Unraveling the Network Intersecting Metabolism and Neurodegeneration
Gentile, F., Doneddu, P. E., Riva, N., Nobile‐Orazio, E., & Quattrini, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207471 · Cited by 58
The potential use of folate and its derivatives in treating psychiatric disorders: A systematic review
Lam, N. S. K., Long, X. X., Li, X., Saad, M., Lim, F., Doery, J. C. G., Griffin, R. C., & Galletly, C. A. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112541 · Cited by 61
Alzheimer’s disease and gut microbiota: does trimethylamine N-oxide (TMAO) play a role?
Arrona Cardoza, P., Spillane, M. B., & Morales Marroquin, E. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuab022 · Cited by 53
Imatinib methanesulfonate reduces hippocampal amyloid-beta and restores cognitive function following repeated endotoxin exposure
Weintraub, M. K., Bisson, C. M., Nouri, J. N., Vinson, B. T., Eimerbrink, M. J., Kranjac, D., Boehm, G. W., & Chumley, M. J. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.05.002 · Cited by 54
Trans-10-hydroxy-2-decenoic acid alleviates LPS-induced blood-brain barrier dysfunction by activating the AMPK/PI3K/AKT pathway
You, M., Miao, Z., Pan, Y., & Hu, F. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172736 · Cited by 53
Emerging therapeutic role of gut microbial extracellular vesicles in neurological disorders
Sun, B., Sawant, H., Borthakur, A., & Bihl, J. C. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1241418 · Cited by 52
Impact of human aging and modern lifestyle on gut microbiota
Gottlieb, M. G. V., Closs, V. E., Junges, V. M., & Schwanke, C. H. A. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1269054 · Cited by 52
Dysbiosis and Alzheimer’s Disease: Cause or Treatment Opportunity?
Janeiro, M. H., Ramírez, M. J., & Solas, M. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-01024-9 · Cited by 51
Anti-Amyloidogenic Effect of Thiacremonone through Anti-Inflamation In Vitro and In Vivo Models
Lin, G. H., Lee, Y., Choi, D., Han, S., Jung, J., Hwang, B. Y., Moon, D. C., Kim, Y. S., Lee, M. K., Oh, K., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111709 · Cited by 49
Lipopolysaccharide Induced Opening of the Blood Brain Barrier on Aging 5XFAD Mouse Model
Barton, S. M., Janve, V. A., McClure, R., Anderson, A. W., Matsubara, J. A., Gore, J. C., & Pham, W. N. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180755 · Cited by 49
Pomegranate polyphenol punicalin ameliorates lipopolysaccharide‐induced memory impairment, behavioral disorders, oxidative stress, and neuroinflammation via inhibition of TLR4‐NF‐кB pathway
Chen, P., Guo, Z., Lei, J., & Wang, Y. (2024) · Phytotherapy Research · doi:10.1002/ptr.8219 · Cited by 48
The low-density lipoprotein receptor-related protein 1 in inflammation
May, P. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32835e809c · Cited by 49
Impact of Microbiome–Brain Communication on Neuroinflammation and Neurodegeneration
Stolzer, I., Scherer, E., Süß, P., Rothhammer, V., Winner, B., Neurath, M. F., & Günther, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914925 · Cited by 49
Cognitive benefits of lithium chloride in APP/PS1 mice are associated with enhanced brain clearance of β-amyloid
Pan, Y., Short, J. L., Newman, S. A., Choy, K. H. C., Tiwari, D., Yap, C., Senyschyn, D., Banks, W. A., & Nicolazzo, J. A. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.03.007 · Cited by 50
Self-citation
Alcohol, inflammation, and blood-brain barrier function in health and disease across development
Vore, A. S., & Deak, T. (2021) · International review of neurobiology · doi:10.1016/bs.irn.2021.06.009 · Cited by 53
The Potential of LPS-Binding Protein to Reverse Amyloid Formation in Plasma Fibrin of Individuals With Alzheimer-Type Dementia
Pretorius, E., Bester, J., Pagé, M., & Kell, D. B. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00257 · Cited by 47
Ethanol Extract of Magnolia officinalis Prevents Lipopolysaccharide‐Induced Memory Deficiency via Its Antineuroinflammatory and Antiamyloidogenic Effects
Lee, Y., Choi, D., Yun, Y., Han, S., Kim, H. M., Lee, K., Choi, S. H., Yang, M., Jeon, H. S., Jeong, J., et al. (2012) · Phytotherapy Research · doi:10.1002/ptr.4740 · Cited by 43
Inflammation Combined with Ischemia Produces Myelin Injury and Plaque-Like Aggregates of Myelin, Amyloid-β and AβPP in Adult Rat Brain
Zhan, X., Cox, C. D., Ander, B. P., Liu, D., Stamova, B. S., Jin, L., Jickling, G. C., & Sharp, F. R. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143072 · Cited by 41
Altered blood–brain barrier transport in neuro-inflammatory disorders
Schenk, G. J., & de Vries, H. E. (2016) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2016.07.002 · Cited by 44
Recent Aspects of Periodontitis and Alzheimer’s Disease—A Narrative Review
Cichońska, D., Mazuś, M., & Kusiak, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052612 · Cited by 47
A ‐kinase anchoring proteins: cAMP compartmentalization in neurodegenerative and obstructive pulmonary diseases
Poppinga, W. J., Muñoz-LLancao, P., González-Billault, C. E., & Schmidt, M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12882 · Cited by 41
Ferulic acid prevents LPS-induced up-regulation of PDE4B and stimulates the cAMP/CREB signaling pathway in PC12 cells
Huang, H., Hong, Q., Tan, H.-L., Xiao, C., & Gao, Y. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.88 · Cited by 40
Antiinflammatory Effects of Orientin-2″-O-Galactopyranoside on Lipopolysaccharide-Stimulated Microglia
Zhou, X., Gan, P., Hao, L., Li, T., Jia, J., Gao, B., Liu, J., Zheng, L. T., & Zhen, X. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00083 · Cited by 39
Autoimmunity, neuroinflammation, pathogen load: A decisive crosstalk in neuropsychiatric SLE
Jeltsch‐David, H., & Muller, S. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.04.005 · Cited by 40
Central and peripheral anti-inflammatory effects of acetylcholinesterase inhibitors
Vaknine, S., & Soreq, H. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108020 · Cited by 41
Mechanism of Salvia miltiorrhiza Bunge extract to alleviate Chronic Sleep Deprivation-Induced cognitive dysfunction in rats
Yin, C., Zhang, M., Jin, S., Zhou, Y., Ding, L., Lv, Q., Huang, Z., Zhou, J., Chen, J., Wang, P., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155725 · Cited by 42
The hypothesis that Helicobacter pylori predisposes to Alzheimer’s disease is biologically plausible
Contaldi, F., Capuano, F., Fulgione, A., Cigliano, R. A., Sanseverino, W., Iannelli, D., Medaglia, C., & Capparelli, R. (2017) · Scientific Reports · doi:10.1038/s41598-017-07532-x · Cited by 38
Treating Autism Spectrum Disorder with Gluten-Free and Casein-Free Diet: The Underlying Microbiota-Gut-Brain Axis Mechanisms
Savelkoul, H. F. J. (2017) · Clinical Immunolgy & Immunotherapy · doi:10.24966/ciit-8844/100009 · Cited by 40
Activation of Inflammation is Associated with Amyloid-β Accumulation Induced by Chronic Sleep Restriction in Rats
Liu, P., Zhao, B., Wei, M., Li, Y., Liu, J., Ma, L., Shang, S., Huo, K., Wang, J., Li, R., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191317 · Cited by 40
A Complex Role of Herpes Viruses in the Disease Process of Multiple Sclerosis
Wuest, S. C., Mexhitaj, I., Chai, N. R., Romm, E., Scheffel, J., Xu, B., Lane, K. C., Wu, T., & Bielekova, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105434 · Cited by 37
Anti-RAGE antibody selectively blocks acute systemic inflammatory responses to LPS in serum, liver, CSF and striatum
Gasparotto, J., Ribeiro, C. T., Bortolin, R. C., Somensi, N., Fernandes, H. S., Teixeira, A. A., Guasselli, M. O. R., Agani, C. A. J. O., Souza, N. C., Grings, M., et al. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.01.008 · Cited by 37
Saliva: a challenging human fluid to diagnose brain disorders with a focus on Alzheimer’s disease
Zürcher, C., & Humpel, C. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.373675 · Cited by 37
Uridine Prodrug Improves Memory in Tg2576 and TAPP Mice and Reduces Pathological Factors associated with Alzheimer's Disease in Related Models
Saydoff, J. A., Olariu, A., Sheng, J. G., Hu, Z., Li, Q., Garcia, R. A. G., Pei, J., Sun, G. Y., & von Borstel, R. W. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130059 · Cited by 36
Novel anti-suprabasin antibodies may contribute to the pathogenesis of neuropsychiatric systemic lupus erythematosus
Ichinose, K., Ohyama, K., Furukawa, K., Higuchi, O., Mukaino, A., Satoh, K., Nakane, S., Shimizu, T., Umeda, M., Fukui, S., et al. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.11.006 · Cited by 34
Multifaceted Alzheimer’s Disease: Building a Roadmap for Advancement of Novel Therapies
Kaur, D., Behl, T., Sehgal, A., Singh, S., Sharma, N., & BUNGAU, S. G. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03415-w · Cited by 34
Species-Dependent Blood-Brain Barrier Disruption of Lipopolysaccharide: Amelioration by ColistinIn VitroandIn Vivo
Jin, L., Nation, R. L., Li, J., & Nicolazzo, J. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00765-13 · Cited by 33
Ceruloplasmin potentiates nitric oxide synthase activity and cytokine secretion in activated microglia
Lazzaro, M., Bettegazzi, B., Barbariga, M., Codazzi, F., Zacchetti, D., & Alessio, M. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0164-9 · Cited by 33
Alzheimer's and Seizures: Interleukin-18, Indoleamine 2,3-Dioxygenase and Quinolinic Acid
Anderson, G., & Ojala, J. O. (2010) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s4603 · Cited by 32
The NLRP3 inflammasome as a bridge between neuro-inflammation in metabolic and neurodegenerative diseases
Söderbom, G., & Zeng, B. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.03.023 · Cited by 32
Shared signaling pathways in Alzheimer’s and metabolic disease may point to new treatment approaches
Suresh, J., Khor, I. W., Kaur, P., Heng, H. L., Torta, F. T., Dawe, G. S., Tai, E. S., & Tolwinski, N. S. (2020) · FEBS Journal · doi:10.1111/febs.15540 · Cited by 34
Gut-Brain axis in Parkinson's disease etiology: The role of lipopolysaccharide
Bhattacharyya, D., & Bhunia, A. (2020) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2020.105029 · Cited by 32
Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats.
Daulatzai, M. A. (2016) · Europe PMC (PubMed Central) · Cited by 31
Modulation of lipopolysaccharide-induced memory insult, γ-secretase, and neuroinflammation in triple transgenic mice by 5-lipoxygenase
Joshi, Y. B., Giannopoulos, P. F., Chu, J., & Praticò, D. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.016 · Cited by 29
Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats.
Daulatzai, M. A. (2016) · Europe PMC (PubMed Central) · Cited by 60
Retracted
Blood-brain barrier penetration of non-replicating SARS-CoV-2 and S1 variants of concern induce neuroinflammation which is accentuated in a mouse model of Alzheimer’s disease
Erickson, M. A., Logsdon, A. F., Rhea, E. M., Hansen, K. M., Holden, S. J., Banks, W. A., Smith, J. L., German, C. N., Farr, S. A., Morley, J. E., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.01.010 · Cited by 29
Self-citation
Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier
Kisler, K., Sagare, A. P., Lazić, D., Bazzi, S. A., Lawson, E. J., Hsu, C.-J., Wang, Y., Ramanathan, A., Nelson, A. R., Zhao, Z., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00597-5 · Cited by 29
White matter injury, cholesterol dysmetabolism, and APP/Abeta dysmetabolism interact to produce Alzheimer’s disease (AD) neuropathology: A hypothesis and review
Sharp, F. R., DeCarli, C. S., Jin, L., & Zhan, X. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1096206 · Cited by 33
Changes of blood-brain-barrier function and transfer of amyloid beta in rats with collagen-induced arthritis
Lai, P.-H., Wang, T.-H., Zhang, N.-Y., Wu, K.-C., Yao, C. J., & Lin, C. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02086-2 · Cited by 28
Inhibition of LPS-induced apoptosis in differentiated-PC12 cells by new triazine derivatives through NF-κB-mediated suppression of COX-2
Ansari, N., Khodagholi, F., Ramin, M., Amini, M., Irannejad, H., Dargahi, L., & Amirabad, A. D. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.10.002 · Cited by 28
A novel study on amyloid β peptide 40, 42 and 40/42 ratio in Saudi autistics
AL-Ayadhi, L. Y., Bacha, A. G. B., Kotb, M., & El-Ansary, A. K. (2012) · Behavioral and Brain Functions · doi:10.1186/1744-9081-8-4 · Cited by 26
Sleep and immunomodulatory responses to systemic lipopolysaccharide in mice selectively expressing interleukin‐1 receptor 1 on neurons or astrocytes
Ingiosi, A. M., & Opp, M. R. (2016) · Glia · doi:10.1002/glia.22961 · Cited by 25
RAGE-NF-κB-PPARγ Signaling is Involved in AGEs-Induced Upregulation of Amyloid-β Influx Transport in an In Vitro BBB Model
Chen, F., Ghosh, A., Hu, M. Y., Long, Y., Sun, H., Kong, L., Hong, H., & Tang, S. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9784-z · Cited by 26
An alkaline phosphatase transport mechanism in the pathogenesis of Alzheimer’s disease and neurodegeneration
Pike, A. F., Kramer, N. I., Blaauboer, B. J., Seinen, W., & Brands, R. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.12.006 · Cited by 26
The Role of Dietary Lipids in Cognitive Health: Implications for Neurodegenerative Disease
Hans, S., Karadimou, A., Mulvihill, J. J., Grabrucker, A. M., & Zabetakis, I. (2022) · Biomedicines · doi:10.3390/biomedicines10123250 · Cited by 23
The Presence and Origin of Autoantibodies Against α4 and α7 Nicotinic Acetylcholine Receptors in the Human Blood: Possible Relevance to Alzheimer's Pathology
Koval, L., Lykhmus, O., Kalashnyk, O., Bachinskaya, N. Y., Kravtsova, G., Soldatkina, M. A., Zouridakis, M., Stergiou, C., Tzartos, S. J., Tsetlin, V. I., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101845 · Cited by 24
Coadministration of Branched-Chain Amino Acids and Lipopolysaccharide Causes Matrix Metalloproteinase Activation and Blood–Brain Barrier Breakdown
Scaini, G., Morais, M. O. D. S., Galant, L. S., Vuolo, F. S., Dall’Igna, D. M., Pasquali, M. A. D. B., Ramos, V. D. M., Gelain, D. P., Moreira, J. C. F., Schuck, P. F., et al. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8618-0 · Cited by 23
Retinoic Acid and the Gut Microbiota in Alzheimer’s Disease: Fighting Back-to-Back?
Endres, K. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190321163705 · Cited by 22
Endothelial dysfunction in neurodegenerative disease: Is endothelial inflammation an overlooked druggable target?
Ritson, M., Wheeler-Jones, C. P. D., & Stolp, H. B. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578363 · Cited by 23
Bacterial lipopolysaccharide induces a dose-dependent activation of neuroglia and loss of basal forebrain cholinergic cells in the rat brain
Houdek, H. M., Larson, J., Watt, J. A., & Rosenberger, T. A. (2014) · Inflammation and Cell Signaling · doi:10.14800/ics.47 · Cited by 22
Design, synthesis and biological assessment of novel N-substituted 3-(phthalimidin-2-yl)-2,6-dioxopiperidines and 3-substituted 2,6-dioxopiperidines for TNF-α inhibitory activity
Luo, W., Yu, Q.-S., Salcedo, I., Holloway, H. W., Lahiri, D. K., Brossi, A. R., Tweedie, D., & Greig, N. H. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.05.029 · Cited by 22
Bacterial Lipopolysaccharides Change Membrane Fluidity with Relevance to Phospholipid and Amyloid Beta Dynamics in Alzheimer’s Disease
Martins, I. J. (2016) · Journal of Microbial & Biochemical Technology · doi:10.4172/1948-5948.1000304 · Cited by 21
Anti-Inflammatory Effects of Asian Fawn Lily (Erythronium japonicum) Extract on Lipopolysaccharide-Induced Depressive-Like Behavior in Mice
Lim, D. W., Park, J., Han, D., Lee, J., Kim, Y. T., & Lee, C.-H. (2020) · Nutrients · doi:10.3390/nu12123809 · Cited by 21
The blood–brain barrier as a treatment target for neurodegenerative disorders
Rust, R., Sagare, A. P., Zhang, M., Zloković, B. V., & Kisler, K. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2480654 · Cited by 21
Brain grey matter volume reduction and anxiety-like behavior in lipopolysaccharide-induced chronic pulmonary inflammation rats: A structural MRI study with histological validation
Ji, C., Yan, Y., Yuan, F., Cao, J., Li, S., Eickhoff, S. B., & Zhang, J. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.11.020 · Cited by 20
The Role of the Gut Microbiota and Microbial Metabolites in the Pathogenesis of Alzheimer’s Disease
Wang, Y. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220417005115 · Cited by 21
Histamine H3 Receptor Integrates Peripheral Inflammatory Signals in the Neurogenic Control of Immune Responses and Autoimmune Disease Susceptibility
Krementsov, D. N., Wall, E. H., Martin, R. A., Subramanian, M., Noubade, R., del Río, R., Mawe, G. M., Bond, J. P., Poynter, M. E., Blankenhorn, E. P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062743 · Cited by 21
Plasma Membrane Protein Profiling in Beta‐Amyloid‐Treated Microglia Cell Line
Correani, V., Francesco, L. D., Mignogna, G., Fabrizi, C., Leone, S., Giorgi, A., Passeri, A., Casata, R., Fumagalli, L., Maras, B., et al. (2017) · PROTEOMICS · doi:10.1002/pmic.201600439 · Cited by 20
Neuromodulatory effect of troxerutin against doxorubicin and cyclophosphamide-induced cognitive impairment in rats: Potential crosstalk between gut–brain and NLRP3 inflammasome axes
Gamal, N. K., El‐Naga, R. N., Ayoub, I. M., & George, M. Y. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114216 · Cited by 18
Mouse models of neurological disorders: A view from the blood–brain barrier
Banks, W. A. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.10.011 · Cited by 22
Self-citation
Brain Endothelial Cells Play a Central Role in the Development of Enlarged Perivascular Spaces in the Metabolic Syndrome
Hayden, M. R. (2023) · Medicina · doi:10.3390/medicina59061124 · Cited by 17
Dopamine selectively modulates lipopolysaccharide-induced TNF-alpha, IFN-gamma and IL-10 within mice tissues.
Matalka, K. Z., Attallah, L. J., Qinna, N. A., & Alhussainy, T. M. (2011) · PubMed · Cited by 17
IL-6 from cerebrospinal fluid causes widespread pain via STAT3-mediated astrocytosis in chronic constriction injury of the infraorbital nerve
Yu, N., Cui, H., Jin, S., Liu, P., Fang, Y., Sun, F., Cao, Y., Yuan, B., Xie, Y., Duan, W., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03049-z · Cited by 19
Investigating the role of P38, JNK and ERK in LPS induced hippocampal insulin resistance and spatial memory impairment
Iloun, P., Abbasnejad, Z., Janahmadi, M., Ahmadiani, A., & Ghasemi, R. (2018) · EXCLI journal · doi:10.17179/excli2018-1387 · Cited by 16
Preclinical Marmoset Model for Targeting Chronic Inflammation as a Strategy to Prevent Alzheimer’s Disease
Philippens, I. H. C. H. M., & Langermans, J. A. M. (2021) · Vaccines · doi:10.3390/vaccines9040388 · Cited by 16
Potential Roles of Myeloid Differentiation Factor 2 on Neuroinflammation and Its Possible Interventions
Oo, T. T., Pratchayasakul, W., Chattipakorn, N., & Chattipakorn, S. C. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02066-2 · Cited by 15
Immunotherapy and Neuroimmunology in Alzheimer‘s Disease: a Perspective from The Blood–Brain Barrier
Banks, W. A. (2009) · Immunotherapy · doi:10.2217/imt.09.72 · Cited by 15
Self-citation
Serum high-sensitivity C-reactive protein and dementia in a community-dwelling Japanese older population (JPSC-AD)
Tachibana, A., Iga, J., Ozaki, T., Yoshida, T., Yoshino, Y., Shimizu, H., Mori, T., Furuta, Y., Shibata, M., Ohara, T., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-57922-1 · Cited by 16
Combining Deep Phenotyping of Serum Proteomics and Clinical Data via Machine Learning for COVID-19 Biomarker Discovery
Beltrami, A. P., Martino, M. D., Dalla, E., Malfatti, M. C., Caponnetto, F., Codrich, M., Stefanizzi, D., Fabris, M., Sozio, E., D’Aurizio, F., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169161 · Cited by 14
Effect of repeated alcohol exposure during the third trimester-equivalent on messenger RNA levels for interleukin-1β, chemokine (C–C motif) ligand 2, and interleukin 10 in the developing rat brain after injection of lipopolysaccharide
Topper, L. A., & Valenzuela, C. F. (2014) · Alcohol · doi:10.1016/j.alcohol.2014.09.032 · Cited by 13
Gut Microorganisms and Neurological Disease Perspectives
Faruqui, N. A., Prium, D. H., Mowna, S. A., Ullah, M. A., Araf, Y., Sarkar, B., Zohora, U. S., & Rahman, M. S. (2021) · Future Neurology · doi:10.2217/fnl-2020-0026 · Cited by 15
A link between microbial infection and cognition?
Swardfager, W., & Black, S. E. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.93 · Cited by 14
The Effect of Gut Microbe Dysbiosis on the Pathogenesis of Alzheimer's Disease (AD) and Related Conditions
Nafady, M. H., Sayed, Z. S., Abdelkawy, D. A., Shebl, M. E., Elsayed, R. A., Ashraf, G. M., Perveen, A., Attia, M. S., & Bahbah, E. I. (2022) · Current Alzheimer Research · doi:10.2174/1567205019666220419101205 · Cited by 13
Cocaine regulates antiretroviral therapy CNS access through pregnane-x receptor-mediated drug transporter and metabolizing enzyme modulation at the blood brain barrier
Ortiz, R. C., Knerler, S. A., Fridman, L. B., Mercado, A., Price, A. C., Rosado‐Franco, J. J., Wilkins, H. N., Flores, B. R., Orsburn, B. C., & Williams, D. W. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00507-3 · Cited by 11
Gene expression of serotonergic markers in peripheral blood mononuclear cells of patients with late-onset Alzheimer's disease
Neshan, M., Campbell, A., Malakouti, S. K., Zareei, M., & Ahangari, G. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04716 · Cited by 13
Enhanced Antioxidant Effects of the Anti-Inflammatory Compound Probucol When Released from Mesoporous Silica Particles
Lau, M., Sealy, B., Combes, V., Morsch, M., & Garcia‐Bennett, A. E. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030502 · Cited by 11
Dementia in diabetes mellitus and atherosclerosis: Two interrelated systemic diseases
Moghaddam, P. M., Ghobadian, R., & Khaleghzadeh‐Ahangar, H. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.01.018 · Cited by 10
Serum-Derived Immunoglobulins Neutralize Adverse Effects of Amyloid-β Peptide on the Integrity of a Blood-Brain Barrier In Vitro Model
Poetsch, V., Neuhaus, W., & Noe, C. R. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-090769 · Cited by 11
Blood-brain barrier at the interface of air pollution-associated neurotoxicity and neuroinflammation
Young, T. L., Zychowski, K. E., Denson, J. L., & Campen, M. J. (2018) · Advances in neurotoxicology · doi:10.1016/bs.ant.2018.10.010 · Cited by 11
Nanoparticles for Diagnosis and/or Treatment of Alzheimer's Disease
Antimisiaris, S. G., Mourtas, S., Markoutsa, E., Σκούρας, Α., & Παπαδιά, Κ. (2014) · Advanced Healthcare Materials · doi:10.1002/9781118774205.ch4 · Cited by 11
Intestinal ischemia–reperfusion and blood–brain barrier compromise: pathways to cognitive dysfunction
Hammed, O. S., Afolabi, O. A., Ajike, R. A., Hezekiah, O. S., Alabi, B. A., Ajao, D., Saka, W. A., Oyekunle, O. S., & Olusola, B. O. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1597170 · Cited by 10
Alzheimer’s Disease: Protective Effects of Mycobacterium vaccae, a Soil-Derived Mycobacterium with Anti-Inflammatory and Anti-Tubercular Properties, on the Proteomic Profiles of Plasma and Cerebrospinal Fluid in Rats
Loupy, K. M., Lee, T., Zambrano, C. A., Elsayed, A. I., D’Angelo, H. M., Fonken, L. K., Frank, M. G., Maier, S. F., & Lowry, C. A. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200568 · Cited by 10

Authors: Jaeger, L. B., Dohgu, S., Sultana, R., Lynch, J. L., Owen, J. B., Erickson, M. A., Shah, G. N., Price, T. O., Fleegal-Demotta, M. A., Butterfiled, D. A., & Banks, W. A.
Affiliations: St. Louis VA Medical Center (US)
University of Kentucky (US)
Corresponding author: Banks, William A.
ORCID: Dohgu, Shinya
Lynch, Jessica L.
Erickson, Michelle A.
Banks, William A.
Venue: Brain, Behavior, and Immunity
Publisher: Elsevier BV
Published: 2009-05
Volume: 23
Issue: 4
Pages: 507-517
ISSN: 0889-1591 (ISSN-L)
DOI: 10.1016/j.bbi.2009.01.017
PMC: PMC2783557
OpenAlex: W2156015902
Cited by: 281
References: 64
Citations by year: 2026: 20 · 2025: 17 · 2024: 23 · 2023: 13 · 2022: 16 · 2021: 21 · 2020: 19 · 2019: 14 · 2018: 11 · 2017: 22 · 2016: 17 · 2015: 9 · 2014: 21 · 2013: 17 · 2012: 13
FWCI: 9.06
Type: journal article
Language: en
Update notices: erratum (2011-11-01)
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Brain Behavior and Immunity (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute on Aging (R01AG029839)
National Institute of Neurological Disorders and Stroke (R01NS050547, R01NS051334)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: Alzheimer's disease, amyloid-beta, blood-brain barrier, lipopolysaccharide, neuroinflammation, indomethacin, LRP1, RAGE, triolein, interleukins, MCP-1
MeSH terms: Receptor for Advanced Glycation End Products, Alzheimer Disease, Animals, Blood-Brain Barrier, Brain, Dose-Response Relationship, Drug, Indomethacin, Inflammation, Lipopolysaccharides, Male, Receptors, Immunologic, Receptors, LDL, Triolein, Blotting, Western, Cytokines, Amyloid beta-Peptides, Cyclooxygenase Inhibitors, Oxidative Stress, Disease Progression, Protein Transport, Tumor Suppressor Proteins, Low Density Lipoprotein Receptor-Related Protein-1, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Lipopolysaccharide alters the blood–brain barrier transport of amyloid β protein: A mechanism for inflammation in the progression of Alzheimer’s disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks